Cargando…
Anti-interleukin-6 therapy for treatment of high platelet counts in cGMP-dependent protein kinase I gene-targeted mice
Autores principales: | Zhang, Lin, Lukowski, Robert, Gaertner, Florian, Lorenz, Michael, Legate, Kyle R, Domes, Katrin, Angermeier, Elisabeth, Hofmann, Franz, Massberg, Steffen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765637/ http://dx.doi.org/10.1186/2050-6511-14-S1-P80 |
Ejemplares similares
-
cGMP kinase: past, presence and future
por: Hofmann, Franz, et al.
Publicado: (2013) -
cGMP kinase I regulates glucagon release
por: Leiss, Veronika, et al.
Publicado: (2009) -
Rescue of cGMP kinase I and the cause of premature death
por: Hofmann, Franz, et al.
Publicado: (2009) -
cGMP kinase I, cardiac hypertrophy and PDE inhibition
por: Patrucco, Enrico, et al.
Publicado: (2011) -
cGMP/cGKI signaling in peripheral vascular smooth muscle does not involve TrpC3 or TrpC6 channels
por: Wegener, Jörg, et al.
Publicado: (2011)